Swiss National Bank’s Harmony Biosciences HRMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.38M Hold
85,100
﹤0.01% 1761
2025
Q4
$3.18M Buy
85,100
+1,600
+2% +$52.6K ﹤0.01% 1619
2025
Q3
$2.3M Buy
83,500
+1,300
+2% +$44.8K ﹤0.01% 1789
2025
Q2
$2.6M Sell
82,200
-700
-0.8% -$22.5K ﹤0.01% 1640
2025
Q1
$2.75M Buy
82,900
+4,700
+6% +$168K ﹤0.01% 1583
2024
Q4
$2.69M Buy
78,200
+17,200
+28% +$591K ﹤0.01% 1686
2024
Q3
$2.44M Sell
61,000
-500
-0.8% -$17.6K ﹤0.01% 1745
2024
Q2
$1.86M Sell
61,500
-2,100
-3% -$63.1K ﹤0.01% 1855
2024
Q1
$2.14M Sell
63,600
-1,500
-2% -$48.1K ﹤0.01% 1802
2023
Q4
$2.1M Sell
65,100
-14,000
-18% -$391K ﹤0.01% 1798
2023
Q3
$2.59M Buy
79,100
+7,300
+10% +$253K ﹤0.01% 1678
2023
Q2
$2.53M Buy
71,800
+20,600
+40% +$711K ﹤0.01% 1739
2023
Q1
$1.67M Sell
51,200
-5,900
-10% -$269K ﹤0.01% 1949
2022
Q4
$3.15M Buy
57,100
+1,100
+2% +$60.5K ﹤0.01% 1603
2022
Q3
$2.48M Buy
56,000
+900
+2% +$43.9K ﹤0.01% 1722
2022
Q2
$2.69M Buy
55,100
+13,600
+33% +$612K ﹤0.01% 1711
2022
Q1
$2.02M Buy
41,500
+3,900
+10% +$159K ﹤0.01% 2039
2021
Q4
$1.6M Hold
37,600
﹤0.01% 2202
2021
Q3
$1.44M Hold
37,600
﹤0.01% 2242
2021
Q2
$1.06M Buy
+37,600
New +$1.13M ﹤0.01% 2455

Other funds holding HRMY

Swiss National Bank's HRMY Position: Q1 2026 in Review

Swiss National Bank held its Harmony Biosciences (HRMY) position steady in Q1 2026 at 85,100 shares worth $2.38M. The position accounts for ﹤0.01% of the portfolio, ranked #1761.

Swiss National Bank first reported a position in HRMY in Q2 2021 and has held it in 20 quarters since. The position peaked at $3.18M in Q4 2025. 309 funds tracked by Wall St. Rank hold HRMY as of Q1 2026.

  • Swiss National Bank held 85,100 shares of Harmony Biosciences worth $2.38M as of Q1 2026.
  • Swiss National Bank left its Harmony Biosciences share count unchanged in Q1 2026.
  • Harmony Biosciences made up ﹤0.01% of Swiss National Bank's portfolio in Q1 2026, its #1761 holding.
  • Swiss National Bank first reported a position in Harmony Biosciences in Q2 2021 and has held it in 20 quarters since.
  • Swiss National Bank's Harmony Biosciences position peaked at $3.18M in Q4 2025.
  • 309 funds tracked by Wall St. Rank held Harmony Biosciences as of Q1 2026.

Based on Swiss National Bank's 13F filing for Q1 2026, filed 7 May 2026.